HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hitoshi Ishii Selected Research

trelagliptin

8/2019Randomized Multicenter Evaluation of Quality of Life and Treatment Satisfaction in Type 2 Diabetes Patients Receiving Once-Weekly Trelagliptin Versus a Daily Dipeptidyl Peptidase-4 Inhibitor.
12/2017Effect of Trelagliptin on Quality of Life in Patients with Type 2 Diabetes Mellitus: Study Protocol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hitoshi Ishii Research Topics

Disease

33Type 2 Diabetes Mellitus (MODY)
02/2021 - 09/2008
9Hypoglycemia (Reactive Hypoglycemia)
02/2021 - 08/2008
6Body Weight (Weight, Body)
02/2021 - 01/2017
3Diabetic Nephropathies (Diabetic Nephropathy)
08/2016 - 01/2014
2Diabetes Mellitus
12/2020 - 11/2013
2Diabetes Complications
01/2020 - 05/2018
2Weight Gain
04/2019 - 01/2012
2Albuminuria
04/2018 - 08/2016
2Insulin Resistance
02/2016 - 03/2014
2Atherosclerosis
01/2016 - 03/2014
1Human Influenza (Influenza)
10/2021
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2021
1Acute Coronary Syndrome
03/2020
1Body Weight Changes
03/2020
1Nausea
01/2020
1Nasopharyngitis
01/2020
1Constipation
01/2020
1Infections
01/2018
1Overweight
01/2018
1Medically Unexplained Symptoms
01/2018
1Polyuria
01/2018
1Hypopituitarism (Sheehan's Syndrome)
10/2017
1Diabetic Retinopathy (Retinopathy, Diabetic)
10/2017
1Chronic Renal Insufficiency
12/2016
1Abdominal Obesity
02/2016
1Lipodystrophy
02/2016
1Non-alcoholic Fatty Liver Disease
02/2016
1Alcoholic Fatty Liver
02/2016
1Cardiovascular Diseases (Cardiovascular Disease)
01/2016
1Hypertension (High Blood Pressure)
01/2016
1Inflammation (Inflammations)
09/2014
1Crohn Disease (Crohn's Disease)
01/2014
1Hyperglycemia
01/2014

Drug/Important Bio-Agent (IBA)

19Insulin (Novolin)FDA Link
02/2021 - 08/2008
5Blood Glucose (Blood Sugar)IBA
03/2020 - 08/2008
4Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
02/2021 - 01/2014
4Glucose (Dextrose)FDA LinkGeneric
02/2021 - 03/2011
3Hypoglycemic Agents (Hypoglycemics)IBA
03/2020 - 01/2018
3dulaglutideIBA
03/2020 - 05/2018
3Dipeptidyl-Peptidase IV InhibitorsIBA
01/2018 - 02/2016
3Uric Acid (Urate)IBA
10/2017 - 08/2016
3AlbuminsIBA
01/2017 - 01/2016
3CreatinineIBA
01/2017 - 01/2016
3C-Reactive ProteinIBA
11/2014 - 03/2014
2dapagliflozinIBA
12/2020 - 01/2018
2trelagliptinIBA
08/2019 - 12/2017
2Glucagon-Like Peptide 1 (GLP 1)IBA
05/2018 - 01/2017
2LiraglutideFDA Link
01/2017 - 01/2014
1Pharmaceutical PreparationsIBA
12/2020
1A-factor (Streptomyces)IBA
03/2019
1LinagliptinIBA
06/2018
1voglibose (Basen)IBA
06/2018
1Insulin Glargine (Lantus)FDA Link
05/2018
1Proton Pump InhibitorsIBA
04/2018
1GlucosidasesIBA
01/2018
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2018
1Sodium-Glucose Transport ProteinsIBA
01/2018
1BiguanidesIBA
01/2018
1Growth Hormone (Somatotropin)IBA
10/2017
1Biomarkers (Surrogate Marker)IBA
10/2017
1Sitagliptin Phosphate (Januvia)FDA Link
06/2017
1Pioglitazone (Actos)FDA Link
02/2016
1ThiazolidinedionesIBA
02/2016
1Antifibrotic AgentsIBA
02/2016
1Collagen Type IV (Type IV Collagen)IBA
02/2016
1alogliptinIBA
02/2016
1Ferritins (Ferritin)IBA
02/2016
1Hemoglobins (Hemoglobin)IBA
01/2016
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2016
1AdipokinesIBA
03/2014
1CytokinesIBA
03/2014
1C-PeptideIBA
01/2014
1BilirubinIBA
01/2014
1insulin aspart protamine drug combination 30:70 insulin aspartIBA
03/2011

Therapy/Procedure

13Therapeutics
02/2021 - 03/2011
13Glycemic Control
02/2021 - 03/2011
1Drug Prescriptions
10/2021
1Diet Therapy (Therapy, Diet)
12/2020
1Exercise Therapy (Therapy, Exercise)
06/2018
1Drug Therapy (Chemotherapy)
01/2018
1Highly Active Antiretroviral Therapy (HAART)
02/2016
1Injections
11/2013